Skip to main content
Log in

Sensitivity of cultured pancreatic carcinoma cells toAcinetobacter glutaminase-asparaginase

  • Published:
In Vitro Aims and scope Submit manuscript

Summary

Cultured human pancreatic carcinoma cells (MIA PaCa-2) have been shown previously to be very sensitive toE. coli l-asparaginase (EC II). The present studies have demonstrated that another enzyme,Acinetobacter glutaminase-asparaginase (AGA) is much more effective in inhibiting cell growth. At the concentration of 0.0025 U/ml of AGA activity the enzyme totally inhibited cell growth, whereas the EC II with the same concentration did not show any effect. The inhibition of cell growth correlated well with inhibition of protein and glycoprotein synthesis. The addition ofl-glutamine at the concentration of 1 mM completely reversed the inhibition of protein synthesis. Similarly, the addition ofl-glutamine at the concentration of 3 mM daily on 3 successive days after adding AGA resulted in significant reversal of growth inhibition. The results of this study indicate that the action of AGA on MIA PaCa-2 is, to a great extent, exerted through itsl-glutaminase activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Yunis, A. A.; Arimura, G. K.; Russin, D. J. Human pancreatic carcinoma (MIA PaCa-2) in continuous culture: Sensitivity to asparaginase. Int. J. Cancer 19: 128–135; 1977.

    Article  PubMed  CAS  Google Scholar 

  2. Schultz, D. R.; Yunis, A. A. Tumor associated antigen(s) in human pancreatic cancer. J. Natl. Cancer Inst. 62: 777–785; 1979.

    PubMed  CAS  Google Scholar 

  3. Wu, M.-C.; Arimura, G. K.; Yunis, A. A. Purification and characterization of a plasminogen activator secreted by cultured human pancreatic carcinoma cells. Biochemistry 16: 1908–1913; 1977.

    Article  PubMed  CAS  Google Scholar 

  4. Wu, M.-C.; Arimura, G. K.; Yunis, A. A. Mechanism of sensitivity of cultured pancreatic carcinoma to asparaginase. Int. J. Cancer 22: 728–733; 1978.

    Article  PubMed  CAS  Google Scholar 

  5. Cooney, D. A.; Handschumacher, R. E.l-Asparaginase andl-asparagine metabolism. Ann. Rev. Pharmacol. 10: 421–440; 1970.

    Article  PubMed  CAS  Google Scholar 

  6. Oettgen, H. F.; Old, L. J.; Boyse, E. A.; Campbell, H. A.; Phillips, F. S.; Clarkson, B. D.; Tallal, L.; Leeper, R. D.; Schwartz, M. K.; Kim, J. H. Inhibition of leukemias in man byl-asparaginase. Cancer Res. 27: 2619–2631; 1967.

    PubMed  CAS  Google Scholar 

  7. Ohnuma, T.; Holland, J. F.; Freeman, A.; Kinks, L. F. Biochemical and pharmacological studies with asparaginase in man. Cancer Res. 30: 2297–2305; 1970.

    PubMed  CAS  Google Scholar 

  8. Wriston, J. C., Jr.; Yellin, T. O.l-Asparaginase: A review. Advanc. Enzymol. 39: 185–248; 1973.

    CAS  Google Scholar 

  9. Becker, F. F.; Broome, J. D.l-Asparaginase: Inhibition of early mitosis in regenerating rat liver. Science 156: 1602–1603; 1967.

    Article  PubMed  CAS  Google Scholar 

  10. Bosmann, H. B.; Kessel, D. Inhibition of glycoprotein synthesis in L5178Y mouse leukemic cells byl-asparaginein vitro. Nature 226: 850–851; 1970.

    Article  PubMed  CAS  Google Scholar 

  11. Mashburn, L. T.; Landin, L. M. Inhibition of thymidine and basic amino acid metabolism in P1798 lymphosarcoma byl-asparaginase. Cancer Res. 34: 313–318; 1974.

    PubMed  CAS  Google Scholar 

  12. Seeber, S.; Weser, U. Inhibition of [3H]thymidine incorporation into rat liver nuclei byE. coli asparaginase. Nature 225: 652–653; 1970.

    Article  PubMed  CAS  Google Scholar 

  13. Roberts, J.; Holcenberg, J. S.; Dolowy, W. C. Isolation, crystallization, and properties ofAchromobacteraceae glutaminase-asparaginase with antitumor activity. J. Biol. Chem. 247: 84–90; 1972.

    PubMed  CAS  Google Scholar 

  14. Roberts, J.; Holcenberg, J. S.; Dolowy, W. C. Antineiplastic activity of highly purified bacterial glutaminase. Nature 277: 1136–1137; 1970.

    Article  Google Scholar 

  15. Roberts, J.; Holcenberg, J. S.; Dolowy, W. C. Glutaminase induced prolonged regression of established Ehrlich carcinoma. Life Sci. 10: 251–255; 1971.

    Article  CAS  Google Scholar 

  16. Holcenberg, J. S.; Robert, J.; Dolowy, W. C. Glutaminase as antineoplastic agents. Prusiner, S.; Stadtman, E. eds. Enzymes as drugs. New York: Academic Press; 1973: 277–292.

    Google Scholar 

  17. Allen, L.; Meck, R.; Yunis, A. A. The inhibition of γ-glutamyltranspeptidase from human pancreatic carcinoma cells by (αS,5S)-α-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125; NSC-163501). Res. Commun. Chem. Pathol. Pharmacol. 27: 175–181; 1980.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was supported in part by USPHS Grant CA 19182. Dr. Wu is recipient of Research Career Development Award Grant CA00686 and Dr. Yunis is a Howard Hughes Investigator.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wu, MC., Arimura, G.K., Holcenberg, J.S. et al. Sensitivity of cultured pancreatic carcinoma cells toAcinetobacter glutaminase-asparaginase. In Vitro 18, 750–754 (1982). https://doi.org/10.1007/BF02796498

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02796498

Key words

Navigation